Histological changes associated with neoadjuvant chemotherapy are predictive of nodal metastases in high-risk prostate cancer patients

Por O’Brien, Catherine, True, Lawrence D., Higano, Celestia S., Rademacher, Brooks L. S., Garzotto, Mark, Beer, Tomasz M.
Publicado em 2010

The role of pharmacologic modulation of autophagy on anal cancer development in an HPV mouse model of carcinogenesis

Por Rademacher, Brooks L., Matkowskyj, Kristina A., Meske, Louise M., Romero, Alexis, Sleiman, Hana, Carchman, Evie H.
Publicado no Virology (2017)

C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): confirmatory results

Por Prins, Renee C., Rademacher, Brooks L., Mongoue-Tchokote, Solange, Alumkal, Joshi J., Graff, Julie N., Eilers, Kristine M., Beer, Tomasz M.
Publicado em 2010

Phase I/II Study of Pre-operative Docetaxel and Mitoxantrone for High-risk Prostate Cancer

Por Garzotto, Mark, Higano, Celestia S., O’Brien, Catherine, Rademacher, Brooks L.S., Janeba, Nicole, Fazli, Ladan, Lange, Paul H., Lieberman, Stephen, Beer, Tomasz M.
Publicado em 2010

CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel - induced cytotoxicity

Por Qian, David Z., Rademacher, Brooks L.S., Pittsenbarger, Janet, Huang, Chung-Ying, Myrthue, Anne, Higano, Celestia S., Garzotto, Mark, Nelson, Peter S., Beer, Tomasz M.
Publicado em 2010

Cluster analysis of acute ascending aortic dissection provides novel insight into mechanisms of distal progression

Por Philip, Jennifer L., De Oliveira, Nilto C., Akhter, Shahab A., Rademacher, Brooks L., Goodavish, Christopher B., DiMusto, Paul D., Tang, Paul C.
Publicado no J Thorac Dis (2017)

ID1 enhances docetaxel cytotoxicity in prostate cancer cells via inhibition of p21

Por Geng, Hao, Rademacher, Brooks L., Pittsenbarger, Janet, Huang, Chung-Ying, Harvey, Christopher T., Lafortune, Marie C., Myrthue, Anne, Garzotto, Mark, Nelson, Peter S., Beer, Tomasz M., Qian, David Z.
Publicado em 2010